ICICI Prudential Healthcare Fund - Direct Plan - Cumulative
ICICI Prudential Mutual Fund · FM: Dharmesh Kakkad, Sharmila D’mello · INF109KC1GH2 · Direct
NAV ₹48.38 AUM ₹6625 Cr as of 09 Nov 2026
Latest available portfolio · Retrieved: 8-Aug-2026 11:26 PM IST · Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | +4.6% | +8.0% | +1.4% | +7.3% | +12.2% | +22.3% | +17.6% | 49/234 | — |
Equity allocation
96.05%
Non-equity allocation (combined)
3.95%
All Equity Holdings (35) latest available
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceuticals Industries Ltd | 808.0 | 12.20% | — |
| 2 | Dr Reddy's Laboratories Ltd | 544.9 | 8.22% | — |
| 3 | Mankind Pharma Ltd | 462.2 | 6.98% | — |
| 4 | Cipla Ltd | 441.9 | 6.67% | — |
| 5 | Alkem Laboratories Ltd | 375.8 | 5.67% | — |
| 6 | Divi's Laboratories Ltd | 368.9 | 5.57% | — |
| 7 | Cohance Lifesciences Ltd | 285.8 | 4.31% | — |
| 8 | Medplus Health Services Ltd | 242.2 | 3.66% | — |
| 9 | Max Healthcare Institute Ltd Ordinary Shares | 205.3 | 3.10% | — |
| 10 | Syngene International Ltd | 191.6 | 2.89% | — |
| 11 | Biocon Ltd | 171.4 | 2.59% | — |
| 12 | Alembic Pharmaceuticals Ltd | 170.9 | 2.58% | — |
| 13 | Abbott India Ltd | 163.7 | 2.47% | — |
| 14 | Lupin Ltd | 152.4 | 2.30% | — |
| 15 | Thyrocare Technologies Ltd | 148.2 | 2.24% | — |
| 16 | Akums Drugs and Pharmaceuticals Ltd | 135.9 | 2.05% | — |
| 17 | Pfizer Ltd | 123.2 | 1.86% | — |
| 18 | Entero Healthcare Solutions Ltd | 111.9 | 1.69% | — |
| 19 | J.B. Chemicals & Pharmaceuticals Ltd | 103.3 | 1.56% | — |
| 20 | Alivus Life Sciences Ltd | 101.9 | 1.54% | — |
| 21 | Blue Jet Healthcare Ltd | 100.2 | 1.51% | — |
| 22 | Rainbow Childrens Medicare Ltd | 95.3 | 1.44% | — |
| 23 | Metropolis Healthcare Ltd | 94.1 | 1.42% | — |
| 24 | Hikal Ltd | 88.5 | 1.34% | — |
| 25 | Medi Assist Healthcare Services Ltd | 88.0 | 1.33% | — |
| 26 | Fine Organic Industries Ltd Ordinary Shares | 88.0 | 1.33% | — |
| 27 | Aurobindo Pharma Ltd | 77.2 | 1.17% | — |
| 28 | Sanofi Consumer Healthcare India Ltd | 75.6 | 1.14% | — |
| 29 | Aarti Drugs Ltd | 70.5 | 1.06% | — |
| 30 | AstraZeneca Pharma India Ltd | 54.6 | 0.82% | — |
| 31 | FDC Ltd | 51.9 | 0.78% | — |
| 32 | Windlas Biotech Ltd | 51.4 | 0.78% | — |
| 33 | Laxmi Dental Ltd | 51.1 | 0.77% | — |
| 34 | Indoco Remedies Ltd | 39.8 | 0.60% | — |
| 35 | Jupiter Life Line Hospitals Ltd | 27.1 | 0.41% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.